This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Karmanos Cancer Institute Announces Successful Completion Of Herrick Cancer Research Challenge





DETROIT, Feb. 18, 2013 /PRNewswire-USNewswire/ -- The Barbara Ann Karmanos Cancer Institute has announced the successful completion of the $3 million Herrick Cancer Research Challenge, with an approximately $5.7 million total impact, exceeding challenge goals. The total impact includes grant dollars contributed by the Herrick Foundation and challenge funds given by donors.

(Logo: http://photos.prnewswire.com/prnh/20071106/KARMANOSLOGO)

The Herrick Foundation made an initial donation of $1 million in 2009 to launch the challenge, which specified that up to $2 million additional dollars would be matched if the additional monies could be raised by Karmanos Cancer Institute over four years. Challenge funds have supported various areas of research at Karmanos, including the Institute's National Oncogenomics and Molecular Imaging Center, pediatric leukemia, lung cancer, new imaging technologies for cancer detection and treatment, and prostate cancer.

"We are thrilled to have successfully met the Herrick Cancer Research Challenge by surpassing our fundraising goals to support the innovative research programs at Karmanos," said Gerold Bepler, M.D., Ph.D., president and CEO of Karmanos. "We thank the Herrick family for their extremely generous gift of $3 million and our other thoughtful donors who helped us meet the challenge.

"Because of this combined support, our scientific researchers can advance their important work in developing new therapies and cutting-edge cancer detection technologies, which include the pursuit of personalized medicine for the benefit of our patients."  

One specific area Herrick Challenge funds helped to support is in prostate cancer research. Researchers at Karmanos and Wayne State University School of Medicine are investigating this form of cancer and the racial disparities behind more aggressive and recurrent prostate cancer. They are using DNA and serum samples from patients to study the association between metabolic syndrome and aggressive prostate cancer. Metabolic syndrome is a cluster of conditions that include increased blood pressure, elevated insulin levels, excess body fat around the waist or abnormal cholesterol levels, which occur together, increasing a person's risk of disease, including aggressive prostate cancer.

The project goal is to develop a way to detect prostate cancer early and to understand its likelihood of recurrence considering prostate cancer is the most prevalent cancer in men. Herrick Funds also have helped to add new research jobs at Karmanos in association with this project and allowed researchers to secure additional, harder-to-obtain funding to continue their work.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 17,826.30 -279.47 -1.54%
S&P 500 2,081.18 -23.81 -1.13%
NASDAQ 4,931.8150 -75.9760 -1.52%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs